{"id":"W3029005700","doi":"10.1200/jco.2020.38.15_suppl.5035","title":"Atezolizumab (atezo) therapy for locally advanced/metastatic urinary tract carcinoma (mUTC) in patients (pts) with poor performance status (PS): Analysis of the prospective global SAUL study.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Atezolizumab; Clinical endpoint; Adverse effect; Internal medicine; Performance status; Post-hoc analysis; Population; Clinical trial; Oncology; Cancer; Surgery; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004734922,0.0006110758,0.001004051,0.0007268054,0.0001556791,0.0009059039,0.0003997173,0.0005843711,0.001397261],"category_scores_gemma":[0.002482577,0.000297538,0.002784912,0.001220361,0.000420255,0.0005308714,0.0007106639,0.0008544885,0.0002095883],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004319458,"about_ca_system_score_gemma":0.0006529429,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00120576,"about_ca_topic_score_gemma":0.003498378,"domain_scores_codex":[0.9989629,0.0006458427,0.00006788642,0.0001222203,0.0001250264,0.00007612103],"domain_scores_gemma":[0.9977409,0.0006876484,0.0008551134,0.0001926433,0.0001184582,0.0004053564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1137195,0.0004663953,0.8355855,0.001586489,0.01057895,0.0002769498,0.0001318924,0.002049704,0.001988956,0.0001442851,0.002869781,0.03060174],"study_design_scores_gemma":[0.01420813,0.01873625,0.9514166,0.0002243729,0.009135801,0.0005259642,0.000131814,0.00179709,0.0004041078,0.0001798463,0.003191295,0.00004858572],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9854321,0.01044073,0.000265026,0.000237515,0.00003291601,0.0001337303,0.0028583,0.00001749599,0.0005822119],"genre_scores_gemma":[0.9931172,0.001854504,0.0002704107,0.0002661188,0.00005986204,0.00008711113,0.004096514,0.000007758201,0.0002404087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004734922,"threshold_uncertainty_score":0.02504092,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06485087495779752,"score_gpt":0.4127311450315476,"score_spread":0.3478802700737501,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}